SELLEST OSAST
Featuring a slide presentation and related discussion from Dr L Elizabeth Budde, including the following topics:
- Overview of approved and investigational CD20 x CD3 bispecific antibodies (BsAbs) in non-Hodgkin lymphoma; key findings from Phase II studies evaluating glofitamab and epcoritamab in relapsed/refractory (R/R) diffuse large B-cell lymphoma (0:00)
- Bringing BsAbs into earlier-line settings; key findings from Phase III studies (7:49)
- Key findings from the Phase III EPCORE DLBCL-1 and EPCORE DLBCL-4 studies and Phase II EPCORE NHL-1 study (14:12)
- A Phase Ib/II study of glofitamab/polatuzumab in R/R large B-cell lymphoma; investigating the use of BsAbs as front-line therapy and as combination therapy (17:58)
- Managing treatment-related adverse events; final takeaways (22:53)
Inglise
Ameerika Ühendriigid
TRANSKRIBEERI 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTSI VARASEMAID OSASID
Otsi kanali Research To Practice | Oncology Videos viimaseid osasid.
MUUD EPISOOD SELLES PODCASTIS
Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:
Introduction (0:00)
EGFR Mutations (2:23)
HER2 Alterations (22:40)
Available and Investigational Immunotherapies (32:14)
Small Cell Lung Cancer (40:48)
CME in…
Featuring a slide presentation and related discussion from Dr Neeraj Agarwal, including the following topics:
Therapeutic targets of systemic therapy in prostate cancer (0:00)
Prevalence of genomic alterations in prostate cancer including PTEN deficiency; prognostic and predictive value (3:5…
Featuring an interview with Dr Neeraj Agarwal, including the following topics:
Impact of PTEN deficiency on PI3K/AKT/mTOR pathway; optimal approaches to testing (0:00)
Approaches to monitoring for disease progression in patients who are PTEN deficient; prognostic significance and implications f…
Featuring an interview with Dr L Elizabeth Budde, including the following topics:
Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00)
Management of BsAb-induced cytokine release syndrome and other toxicities (7:35)
Use of BsAbs in t…
Vastutamatussäte: Sellele lehele manustatud taskuhäälingusaade ja kunstiteosed pärinevad Dr Neil Love-lt, mis on selle omaniku omand ja ei ole seotud ettevõttega Listen Notes, Inc.
MUUDA
Aitäh, et aitad hoida podcastide andmebaasi ajakohasena.
